Sutro Biopharma, Inc.

STRO

$19.89

-3.16%

2026-09-04 09:39:48 EDT-$0.65

Healthcare

Biotechnology

NASDAQ

Active Trading

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective ...

Historical Employee Count of STRO

Current

137

Change

-55.81%

Minimum

137

Maximum

310

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	137	10-K	Mar 23, 2026	View
Dec 31, 2024	310	10-K	Mar 13, 2025	View
Dec 31, 2023	302	10-K	Mar 25, 2024	View
Dec 31, 2022	278	10-K	Mar 30, 2023	View
Dec 31, 2021	224	10-K	Feb 28, 2022	View

Supply Chain of STRO

Upstream / Downstream / Proxies

Upstream

Boehringer Ingelheim BioXcellenceVGXI, Inc. (subsidiary of GeneOne Life Science)KOSDAQ:011000The Scripps Research InstituteThird-party CROs and CMOs (various unnamed)GeneOne Life Science, Inc.KOSDAQ:011000

Downstream

Ipsen S.A.EURONEXT:IPNAstellas Pharma Inc.TSE:4503Merck KGaA (Darmstadt, Germany)XETRA:MRKBristol Myers Squibb CompanyNYSE:BMYTasly Pharmaceutical Group Co., Ltd.SHA:600535Vaxcyte, Inc.NASDAQ:PCVX

Proxies

Mersana Therapeutics, Inc.NASDAQ:MRSN ADC Therapeutics SANYSE:ADCT Zymeworks Inc.NASDAQ:ZYMEImmunoGen, Inc. (now AbbVie)Unconfirmed

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer